Delivery Order SPE2DB22D6029-SPE2DB25FLVFS
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 200 milliliter vials of the pharmaceutical Nicardipine 20 milligrams per 200 milliliter 0.9% sodium chloride solution. The order has a potential value of $1,239.70 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,967.75 firm fixed-price delivery order is for the supply of 30 mg nicardipine capsules, a medication used to treat cardiovascular conditions. The award is not designated as a set-aside contract. It is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Cardizem CD 180 mg capsules (30-count) with a ceiling value of $2,200.35. This firm fixed price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 10, 2025, for the supply of Norepinephrine 8 mg/250 mL in D5W solution with a ceiling value of $1,549.16. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,453.56 for 500 tablets of Felodipine ER 10 mg, a pharmaceutical product used in cardiovascular treatment. Awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, this firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Nifedipine ER 60 mg tablets (300-count units) with a ceiling value of $2,153.32. This non-set-aside, firm fixed-price delivery order represents a competitively awarded contract with an ultimate completion date of August 13, 2025. The contract is performed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, leveraging the company's extensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nifedipine ER 60 mg tablets (300-count) with a contract value of $3,880.20. The award was made on September 16, 2025, with an ultimate completion date of September 17, 2025, under a firm fixed-price delivery order structure. This contract was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,564,322,407 units of the pharmaceutical product Nisoldipine ER 30 mg tablets. The contract is a firm-fixed price delivery order with a ceiling value of $1,509.86 and an ultimate completion date of April 19, 2024. This order is placed under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,846.90 on September 29, 2025, for 500 tablets of Amlodipine 5mg. The award was made without a set-aside designation through a firm fixed-price contract vehicle under the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of October 27, 2025. This delivery order represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order valued at $1,006.89 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Nifedipine ER 30 mg tablets (100-count bottles). This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of September 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was awarded through open competition. This...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB25FLVFSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 8, 2025, for the supply of Nicardipine 20mg/200ml in 0.9% Sodium Chloride solution, with a ceiling value of $2,866.98 and an ultimate completion date of June 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is listed as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The delivery order for Nicardipine, a cardiovascular medication used primarily for blood pressure management, represents a typical transactional fulfillment under this expansive pharmaceutical framework contract that supports Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 6/8/25 |